N/A
Manufactured by Allergan, Inc.
269,296 FDA adverse event reports analyzed
Last updated: 2026-05-19
Lexapro is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Allergan, Inc.. The most commonly reported adverse reactions for Lexapro include FATIGUE, NAUSEA, DRUG INEFFECTIVE, HEADACHE, DIARRHOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for Lexapro.
Out of 136,857 classified reports for Lexapro:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 269,296 FDA FAERS reports that mention Lexapro. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include FATIGUE, NAUSEA, DRUG INEFFECTIVE, HEADACHE, DIARRHOEA, ANXIETY. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Allergan, Inc. in connection with Lexapro. Always verify the specific product and NDC with your pharmacist.
Explore other medications manufactured by Allergan, Inc. and compare their safety profiles:
The following drugs share commonly reported adverse reactions with Lexapro: